Potentially inappropriate medication prescriptions among elderly nursing home residents: their scope and associated resident and facility characteristics

Health Services Research
Denys T LauAlan Lyles

Abstract

To estimate the scope of potentially inappropriate medication prescriptions (PIRx) among elderly residents in U.S. nursing homes (NHs), and to examine associated resident and facility characteristics. The 1996 Medical Expenditure Panel Survey Nursing Home Component (MEPS NHC), a survey of a nationally representative sample of NHs and residents. The PIRx, defined by Beers's consensus criteria (1991, 1997), was identified using up to a year's worth of NH prescribed medicine data for each resident. The study sample represented 1.6 million NH residents (n=3,372). At a minimum, 50 percent of all residents aged 65 or older, with an NH stay of three months or longer received at least one PIRx in 1996. The most common PIRx involved propoxyphene, diphenhydramine, hydroxyzine, oxybutynin, amitriptyline, cyproheptadine, iron supplements, and ranitidine. Resident factors associated with greater odds of PIRx were Medicaid coverage, no high school diploma, and nondementia mental disorders. Facility factors were more beds and lower RN-to-resident ratio. Factors associated with lower odds of PIRx were fewer medications, residents with communication problems, and being in an accredited NH. Onsite availability of pharmacists or mental health pro...Continue Reading

References

Oct 15, 1992·Annals of Internal Medicine·M H BeersJ C Beck
Aug 1, 1995·Annals of Internal Medicine·J Avorn, J H Gurwitz
Mar 1, 1995·Journal of Health and Social Behavior·R M Andersen
Mar 1, 1997·American Journal of Public Health·D L SporeJ Hiris
Jul 1, 1997·The Annals of Pharmacotherapy·R R Aparasu, S E Fliginger
Jan 8, 1996·Journal of Health Economics·J W Cohen, W D Spector
Jul 20, 1999·JAMA : the Journal of the American Medical Association·P A Rochon, J H Gurwitz
May 16, 2000·Pharmacotherapy·J T HanlonR D Horner
Aug 5, 2000·The Annals of Pharmacotherapy·R R Aparasu, J R Mort
Sep 1, 2000·The American Journal of Medicine·J H GurwitzD W Bates
Sep 14, 2000·The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences·C HarringtonP Beutel
Oct 12, 2000·Archives of Internal Medicine·J R Mort, R R Aparasu
Feb 24, 2001·Journal of Health & Social Policy·N G Castle
Aug 31, 2001·American Journal of Public Health·C HarringtonD U Himmelstein
Jun 11, 2002·Medical Care Research and Review : MCRR·Bruce Stuart, Becky Briesacher
Aug 3, 2002·Archives of Internal Medicine·Jerry H GurwitzUNKNOWN Food and Drug Administration (U.S.)
Feb 11, 2004·Archives of Internal Medicine·Margie Rauch Goulding

❮ Previous
Next ❯

Citations

Jan 13, 2010·Archives of Internal Medicine·Yong ChenJerry H Gurwitz
Aug 7, 2012·International Journal of Clinical Pharmacy·Mohd Shahezwan Abd WahabStefan R Kowalski
May 28, 2013·International Journal of Clinical Pharmacy·Eun Kyung Lee, Yu Jeung Lee
Jun 26, 2008·Journal of General Internal Medicine·Jessica J JalbertKate L Lapane
Oct 7, 2011·Journal of General Internal Medicine·Yuhua BaoMartha L Bruce
Mar 7, 2012·The Gerontologist·Laura M WagnerNicholas G Castle
Sep 1, 2012·Health Care Management Review·Jane Banaszak-HollGretchen Spreitzer
Oct 6, 2012·BMJ Quality & Safety·Reece HinchcliffJeffrey Braithwaite
Feb 4, 2014·Clinical Interventions in Aging·Saná M H Al AqqadBalamurugan Tangiisuran
Sep 1, 2011·Canadian Geriatrics Journal : CGJ·Corinne E FischerDonald Wasylenki
Dec 17, 2008·The Gerontologist·Robert L Kane, John R Mach
Apr 12, 2014·International Journal of Clinical Pharmacy·Line Due JensenJanne Petersen
Jan 18, 2008·The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists·Kevin T Bain, Douglas J Weschules
Mar 10, 2010·The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists·Juliana LocatelliAngela Tavares Paes
Oct 7, 2014·Journal of the American Medical Directors Association·Charlène CoolMaryse Lapeyre-Mestre
Oct 27, 2015·Journal of the American Pharmacists Association : JAPhA·Nandita KachruRajender R Aparasu
Aug 26, 2009·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Patricia BruckenthalLori Reisner
Sep 11, 2012·Journal of the American Medical Directors Association·Gotaro KojimaKamal Masaki
Apr 17, 2012·Clinics in Geriatric Medicine·Bruce K TamuraKamal H Masaki
Apr 17, 2012·Clinics in Geriatric Medicine·Bruce K TamuraKamal H Masaki
Oct 28, 2011·The American Journal of Geriatric Pharmacotherapy·Rituparna BhattacharyaRajender R Aparasu
Aug 16, 2011·Journal of the American Medical Directors Association·Susan E BronskillPaula A Rochon
Jun 7, 2011·Clinics in Geriatric Medicine·Gwendolen T Buhr, Miguel A Paniagua
Apr 1, 2011·Journal of the American Medical Directors Association·Bruce K TamuraKamal H Masaki
Mar 17, 2010·The American Journal of Geriatric Pharmacotherapy·Lisa L DwyerElizabeth A Rechtsteiner
May 5, 2010·Journal of the American Medical Directors Association·Louise M Murray, Sarah B Laditka
May 26, 2009·The Nursing Clinics of North America·Barbara Messinger-Rapport
Jul 31, 2007·Journal of the American Geriatrics Society·Alec B O'ConnorRobert G Holloway
Jan 1, 2008·Research in Nursing & Health·Donna M FickJennifer L Waller
May 21, 2013·Rehabilitation Nursing : the Official Journal of the Association of Rehabilitation Nurses·Laura M WagnerNicholas G Castle
Nov 14, 2013·Journal of the American Geriatrics Society·David DosaOrna Intrator
Feb 10, 2011·International Journal of Older People Nursing·Carmel HughesNgaire Kerse
Mar 22, 2014·International Journal of Geriatric Psychiatry·Judith A LucasStephen Crystal
Apr 22, 2010·Journal of the American Geriatrics Society·Alex Z FuJenny Z Jiang
Jul 25, 2006·The American Journal of Geriatric Pharmacotherapy·Katrina T CannonMiguel A Zuniga
Jun 22, 2006·The American Journal of Emergency Medicine·Kevin M TerrellDouglas K Miller
May 30, 2006·The American Journal of Geriatric Pharmacotherapy·Richard A HansenTimothy S Carey

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.